Zymeworks Inc.
ZYME
$23.90
-$0.13-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.41M | 2.52M | 27.61M | 48.73M | 27.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.41M | 2.52M | 27.61M | 48.73M | 27.11M |
| Cost of Revenue | 34.46M | 31.24M | 35.58M | 34.45M | 35.74M |
| Gross Profit | -32.05M | -28.72M | -7.96M | 14.28M | -8.63M |
| SG&A Expenses | 15.07M | 15.43M | 14.15M | 14.95M | 16.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.53M | 46.67M | 49.72M | 49.40M | 52.72M |
| Operating Income | -47.12M | -44.15M | -22.11M | -674.00K | -25.61M |
| Income Before Tax | -46.35M | -41.48M | -18.27M | 2.13M | -22.14M |
| Income Tax Expenses | -2.19M | -270.00K | 1.34M | -186.00K | 496.00K |
| Earnings from Continuing Operations | -44.16M | -41.21M | -19.60M | 2.32M | -22.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.16M | -41.21M | -19.60M | 2.32M | -22.64M |
| EBIT | -47.12M | -44.15M | -22.11M | -674.00K | -25.61M |
| EBITDA | -45.98M | -43.07M | -20.56M | 1.82M | -23.02M |
| EPS Basic | -0.59 | -0.55 | -0.26 | 0.03 | -0.30 |
| Normalized Basic EPS | -0.39 | -0.34 | -0.15 | 0.02 | -0.18 |
| EPS Diluted | -0.59 | -0.55 | -0.26 | 0.03 | -0.30 |
| Normalized Diluted EPS | -0.39 | -0.34 | -0.15 | 0.02 | -0.18 |
| Average Basic Shares Outstanding | 74.67M | 75.34M | 75.77M | 75.34M | 75.17M |
| Average Diluted Shares Outstanding | 74.69M | 75.34M | 75.78M | 77.38M | 75.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |